COMMUNIQUÉS West-GlobeNewswire

Akorn Receives FDA Warning Letter
09/01/2019
LAKE FOREST, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a warning letter, dated January 4, from the U.S. Food and [...]
Moleculin Announces Patient Recruitment Begins in Annamycin Clinical Trial In Poland
09/01/2019
Received European approval to ship Annamycin into Poland to start treating patients HOUSTON, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage [...]
Nephros Announces Preliminary Financial Results for Fiscal Year 2018
09/01/2019
Anticipates $5.6-5.7 Million Total Revenue; Product Revenue Growth Over 50% SOUTH ORANGE, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company [...]
CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference
09/01/2019
LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will host an investor presentation at the Benzinga Cannabis [...]
Resonant Inc. Adds New Filter IP Standard Library and 5G Information to Company Website
09/01/2019
Provides additional information on website for new Filter IP Standard Library, including roadmap Unveils XBAR 5G video GOLETA, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in [...]
Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director
09/01/2019
PLAINSBORO, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Rhonda Germany Ballintyn to [...]
Athenex Announces Completion of Target Enrollment in the Oraxol Phase III Study
09/01/2019
BUFFALO, N.Y., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Assertio Therapeutics Announces Amendment of its Senior Secured Credit Facility
09/01/2019
Agreement Provides Greater Financial Flexibility as Company Continues to Reduce Debt LAKE FOREST, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has amended [...]
Auxly Announces Completion of Inverell S.A. Acquisition
09/01/2019
VANCOUVER, British Columbia, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (the " Company ") is pleased to announce that, further to its previous releases, it has completed the [...]
MediPharm Labs Announces Increased Management Shareholdings and Stock Option Grant
09/01/2019
TORONTO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS; OTCQB: MLCPF) (the “ Company ” or “ MediPharm Labs ”), a specialized, research-driven cannabis extraction business, fully licensed under the [...]
INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis
09/01/2019
Company’s Proprietary Formulation Continues to Show Promise as Potential Alternative to Intramuscular Injection PHOENIX, Jan. 09, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the [...]
Correction: Bilan Annuel du contrat de liquidité contracté par Eurobio Scientific avec Louis Capital Markets
09/01/2019
BILAN ANNUEL DU CONTRAT DE LIQUIDITE CONTRACTE PAR EUROBIO SCIENTIFIC AVEC LOUIS CAPITAL MARKETS Paris, le 7 janvier 2019 – 17h45 Au titre du contrat de liquidité portant sur les actions de la société Eurobio Scientific [...]
Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2019 AGM of Orion Corporation
09/01/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 9 JANUARY 2019 at 12.40 EET Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2019 AGM of Orion Corporation The Nomination Committee [...]
Announcement About Convening of the Extraordinary General Meeting of Shareholders of Joint Stock Company Olainfarm
09/01/2019
Management Board of the Joint Stock Company Olainfarm (JSC Olainfarm), unitary registration number. 40003007246, registered address: Rupnicu iela 5, Olaine, LV-2114, announces that on January 08th, 2019, joint request [...]
De-listing and cancellation of trading of Shire Shares
09/01/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR [...]
Basilea reports positive interim results from registrational phase 2 study with oncology drug candidate derazantinib in intrahepatic cholangiocarcinoma (iCCA)
09/01/2019
21% objective response rate with six confirmed partial responses from 29 evaluable patients 83% disease control rate Safety profile and tolerability of continuous dosing schedule confirmed Basel, Switzerland, January 09 [...]
RadioMedix and Curium Announce FDA Fast Track Designation For 64Cu-Dotatate.
09/01/2019
Houston, TX and St. Louis, MO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that their investigational diagnostic radiopharmaceutical, 64 Cu-Dotatate, was granted [...]
Mesa's Board Announces Death of Board Member H. Stuart Campbell
09/01/2019
Lakewood, Colo., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that H. Stuart Campbell, Mesa’s Lead Independent Director has died at the [...]
Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/2019
LAKE FOREST, Ill., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Akorn granted an inducement equity award in accordance with Nasdaq Listing Rule 5635(c)(4) pursuant to an employment [...]

Pages